HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients—Sorafenib, Pemetrexed, and Cisplatin: Outcome Measures: Prior Concurrent Therapy

Read about the concurrent therapy for a current clinical trial about the use of Sorafenib, Pemetrexed, and Cisplatin for patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only

Prior Concurrent Therapy:

  • At least 3 weeks since prior systemic therapy (6 weeks for bevacizumab) and recovered
  • At least 3 months since prior pemetrexed disodium or cisplatin
  • No prior sorafenib tosylate
  • More than 4 weeks since prior major surgery or open biopsy
  • No NSAIDs or salicylates for 2 days before, during, and for 2 days after pemetrexed disodium administration
  • No NSAIDs or salicylates with a long half-life (e.g., naproxen, piroxicam, diflunisal, albumetone) for 5 days before, during, and for 2 days after pemetrexed disodium administration
  • No concurrent Hypericum perforatum
  • Concurrent anti-coagulation treatment with warfarin or heparin allowed

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease. If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Outcome of Sorafenib study on mesothelioma
Study objectives for Sorafenib on mesothelioma
Disease traits in Sorafenib study on mesothelioma
Sorafenib study on mesothelioma patient
Sorafenib therapy for mesothelioma patients
Contacts: Sorafenib study on mesothelioma patients


RETURN BACK TO
Mesothelioma
Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Study objectives for Sorafenib on mesothelioma Clinical trial objectives for Sorafenib trial to treat mesothelioma
Objectives of Sorafenib test to treat mesothelioma patients

Sorafenib therapy for mesothelioma patients Clinical trial and therapy for use of Sorafenib to treat mesothelioma
Read how Sorafenib therapy is tested to treat mesothelioma patients

Sorafenib study on mesothelioma patients Clinical trial on the use of Sorafenib to treat mesothelioma patients
Read how Sorafenib is being tested to treat mesothelioma patients